Successful use of recombinant activated factor VII (Novoseven®) in controlling severe intra-abdominal bleeding after liver needle biopsy

Thrombosis and Haemostasis

Volumn 87, Issue 2, 2002, Pages 346-347

  Hoffman, R ^a   Mahajana, A ^a   Agmon, P ^a   Baruch, Y ^a   Brenner, B ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABDOMINAL BLEEDING; ABDOMINAL PAIN; ADULT; BLOOD CLOTTING DISORDER; CASE REPORT; CONVALESCENCE; CRYSTALLOID; DISEASE SEVERITY; DOSE RESPONSE; DRUG USE; FEMALE; HEMORRHAGIC SHOCK; HUMAN; LAPAROTOMY; LETTER; LIVER BIOPSY; NEEDLE BIOPSY; PRIORITY JOURNAL; THROMBOCYTE COUNT;

EID: 0036173284     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613000     Document Type: Letter

References (9)

1. Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: Safety, monitoring and cost effectiveness
2. Platelet activity of high dose factor VIIa in independent of tissue factor
3. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency
4. Treatment of traumatic bleeding with recombinant factor VIIa
5. Treatment of a severely bleeding patient without pre-existing coagulopathy with activated recombinant factor VII
6. Recombinant factor VIIa (NOVOSEVEN®) as a hemostatic agent
7. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study
8. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: A pilot study
9. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries